Experimental Serotonergic Agents for the Treatment of Schizophrenia
Enrico Capuzzi,1 Alice Caldiroli,1 Veronica Ciscato,2 Stefania Russo,2 Massimiliano Buoli3,4 1Psychiatric Department, Azienda Socio Sanitaria Territoriale Monza, Monza, Italy; 2Department of Medicine and Surgery, University of Milano Bicocca, Monza, MB, 20900, Italy; 3Department of Neurosciences and...
Main Authors: | Capuzzi E, Caldiroli A, Ciscato V, Russo S, Buoli M |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2021-02-01
|
Series: | Journal of Experimental Pharmacology |
Subjects: | |
Online Access: | https://www.dovepress.com/experimental-serotonergic-agents-for-the-treatment-of-schizophrenia-peer-reviewed-fulltext-article-JEP |
Similar Items
-
Correlation of neurocognitive deficits with positive and negative symptoms in schizophrenia
by: Richa Priyamvada, et al.
Published: (2021-01-01) -
Negative and Cognitive Symptoms of Schizophrenia: Are there Adequate Pharmacological Treatments?
by: O. Vasiliu
Published: (2022-06-01) -
Role of Serotonin in Schizophrenia
by: Ebru Oztepe Yavasci, et al.
Published: (2012-06-01) -
Magnetic resonance imaging in studying schizophrenia, negative symptoms and the glutamate system
by: Oliver eGruber, et al.
Published: (2014-04-01) -
The serotonergic system and cognitive function
by: Švob Štrac Dubravka, et al.
Published: (2016-01-01)